(Q35114490)

English

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease (English)

1 reference

Europe PubMed Central

6 August 2017

Alzheimer's Disease Neuroimaging Initiative

0 references

Alzheimer's disease

0 references

0 references

3

object named as

Harald Hampel

1 reference

Europe PubMed Central

6 August 2017

John Q. Trojanowski

9

object named as

John Q Trojanowski

1 reference

Europe PubMed Central

6 August 2017

John Anthony Hardy

4

object named as

John Hardy

1 reference

Europe PubMed Central

6 August 2017

8

object named as

Eric Siemers

1 reference

Europe PubMed Central

6 August 2017

2

object named as

Douglas Galasko

1 reference

Europe PubMed Central

6 August 2017

author name string

Richard A Frank

1

1 reference

Europe PubMed Central

6 August 2017

Mony J de Leon

5

1 reference

Europe PubMed Central

6 August 2017

Pankaj D Mehta

6

1 reference

Europe PubMed Central

6 August 2017

Joseph Rogers

7

1 reference

Europe PubMed Central

6 August 2017

National Institute on Aging Biological Markers Working Group

10

1 reference

Europe PubMed Central

6 August 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

6 August 2017

Neurobiology of Aging

1 reference

Europe PubMed Central

6 August 2017

24

1 reference

Europe PubMed Central

6 August 2017

521-536

1 reference

Europe PubMed Central

6 August 2017

4

1 reference

Europe PubMed Central

6 August 2017

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative damage to DNA: relation to species metabolic rate and life span

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet APP isoform ratios correlate with declining cognition in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased oxidative damage to DNA in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of neuronal thread protein expression with neuritic sprouting: relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human kallikrein 6 as a biomarker of alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential Level of Platelet Amyloid beta Precursor Protein Isoforms: An Early Marker for Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer's disease: detection of highly mutated V regions in both heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum p97 levels as an aid to identifying Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased nuclear DNA oxidation in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical-neuropathological correlations in Alzheimer's disease and related dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol, A beta and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibodies to amyloid-beta and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic accuracy of Alzheimer's disease: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lewy Body Pathology in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of synaptic proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Homocysteine, vitamin B6, and vascular disease in AD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the DPC IMMULITE 2000 assay for total homocysteine in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodological considerations and factors affecting 8-hydroxy-2-deoxyguanosine analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease and oxygen radicals: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurofilament protein levels in CSF are increased in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-peptide immunization: a possible new treatment for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal and abnormal biology of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Complement activation by neurofibrillary tangles in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0197-4580(03)00002-2

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35114490&oldid=1975379049"